Pyng Medical Corp

Saving lives by saving time through innovation in resuscitation®

Pyng Medical Corp. Creates Senior Advisory Board

June 22nd, 2009

Vancouver, BC – Pyng Medical announces that it has created a senior advisory board to advise its Board of Directors. The advisory board will review and advise on strategic corporate initiatives, business and competitive issues, industry trends, and potential acquisitions.

This advisory board will be lead by Pyng’s director, Mr. L. J. “Bud” Evans. The initial appointees to the advisory board are LTG (R) Ron Blanck MD and LTG(R) Charles Roadman II MD and Mr Brian Bristol. Their brief biographies are below:

  • Dr. Blanck, D.O. is Vice Chairman & Partner of Martin, Blanck & Assoc. and Former Surgeon General of the US Army & Commander of the US Army Medical Command, Lt. General US Army (Ret.)
  • Dr. Charles Harvey Roadman II, MD, CNA is Chairman of the Board of Trustee of the Altarum Institute and a Former President and CEO American Care Health Association and served as Surgeon General USAF, Lt. General USAF (Ret )
  • Mr. Bristol, M.B.A., Ph.D., was most recently Senior Managing Director and Head of Investment Banking at W. R. Hambrecht + Co from 2003 to the present.

Kevin O’Neill stated on behalf of the board of directors: “We are thrilled to have Bud lead a team of advisors of such calibre and experience to help in our various strategic initiatives and in particular, penetrating new markets.”

On behalf of the Board of Directors of Pyng Medical Corp.

“Kevin O’Neill”
Kevin O’Neill, Director
Pyng Medical Corp.

About Pyng Medical Corp.
Pyng is a leader in resuscitation innovation with simple-to-use and highly effective
products including FAST1® Intraosseous Infusion System, the FASTx™ System, T-POD®
Pelvic Stabilizer, and MAT® Tourniquet. The Company is awaiting FDA approval of the
CRIC Cricothyrotomy System which is currently under final development. The
Company plans to submit an application for FDA approval of the FASTx™ System which is
currently still under development.

For More Information

George Dorin
Pyng Medical Corp.
(604) 303-7964
www.pyng.com

Safe Harbour Statement; Forward-Looking Statements: This release may contain forward-looking statements based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking statements may be identified by words like "expects", "anticipates", "plans", "intends", "projects", "indicates", and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in documents which may be filed with the British Columbia Securities Commission, the Alberta Securities Commission, the Ontario Securities Commission, the TSX Venture Exchange, as well as other USA Commissions, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies and economic conditions, including inflation, interest and foreign currency exchange rates, of countries in which the Company does business; competitive pressures; successful integration of structural changes, including restructuring plans, acquisitions, divestitures and alliances; cost of raw material, research and development of new products, including regulatory approval and market acceptance; and seasonality of sales in some products.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.